Malignant melanoma.

ISRN Dermatology Pub Date : 2012-01-01 Epub Date: 2012-12-04 DOI:10.5402/2012/308279
Aída Ortega Candil, Cristina Rodríguez Rey, José Luis Carreras Delgado
{"title":"Malignant melanoma.","authors":"Aída Ortega Candil,&nbsp;Cristina Rodríguez Rey,&nbsp;José Luis Carreras Delgado","doi":"10.5402/2012/308279","DOIUrl":null,"url":null,"abstract":"<p><p>Nuclear medicine plays an essential role in the correct staging of patients suffering from melanoma. Both sentinel lymph node biopsy (SLNB) and positron emission tomography (PET) represent its main diagnostic tools. SLNB is the choice procedure for lymphatic regional staging of these patients, including the result of this technique in the 2002 American Joint Cancer Committee melanoma staging. SLNB sensitivity is superior than PET/CT for the detection of lymphatic micrometastases in early stages of the disease. PET/CT is mainly used in confirming clinical metastases suspected, detection of recurrences, and recurrence restaging. PET/CT has also shown superiority against conventional diagnostic methods in the detection of distant metastases, being able to detect illness even six months earlier than those methods.</p>","PeriodicalId":14682,"journal":{"name":"ISRN Dermatology","volume":"2012 ","pages":"308279"},"PeriodicalIF":0.0000,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5402/2012/308279","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ISRN Dermatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5402/2012/308279","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2012/12/4 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

Abstract

Nuclear medicine plays an essential role in the correct staging of patients suffering from melanoma. Both sentinel lymph node biopsy (SLNB) and positron emission tomography (PET) represent its main diagnostic tools. SLNB is the choice procedure for lymphatic regional staging of these patients, including the result of this technique in the 2002 American Joint Cancer Committee melanoma staging. SLNB sensitivity is superior than PET/CT for the detection of lymphatic micrometastases in early stages of the disease. PET/CT is mainly used in confirming clinical metastases suspected, detection of recurrences, and recurrence restaging. PET/CT has also shown superiority against conventional diagnostic methods in the detection of distant metastases, being able to detect illness even six months earlier than those methods.

Abstract Image

Abstract Image

Abstract Image

恶性黑色素瘤。
核医学在黑色素瘤患者的正确分期中起着至关重要的作用。前哨淋巴结活检(SLNB)和正电子发射断层扫描(PET)是其主要诊断工具。SLNB是这些患者淋巴区域分期的首选手术,包括该技术在2002年美国联合癌症委员会黑色素瘤分期中的结果。SLNB在疾病早期检测淋巴微转移的敏感性优于PET/CT。PET/CT主要用于临床疑似转移的确认、复发的检测、复发的再分期。PET/CT在检测远处转移方面也显示出优于传统诊断方法的优势,甚至能够比这些方法早6个月发现疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信